Here, by using an already described experimental approach [14], we report the screening of a library of 640 Food and Drug Administration (FDA) approved molecules, aimed at searching for compounds able to decrease PHOX2B expression in neuroblastoma cells through regulation of gene transcription and/or mRNA stability. Here, PHOX2B is linked to neuroblastoma.